BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27864417)

  • 21. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients.
    Wohlmuth C; Wohlmuth-Wieser I; May T; Vicus D; Gien LT; Laframboise S
    Am J Clin Dermatol; 2020 Apr; 21(2):285-295. PubMed ID: 31784896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
    Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
    J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphovascular invasion as a prognostic factor in melanoma.
    Egger ME; Gilbert JE; Burton AL; McMasters KM; Callender GG; Quillo AR; Brown RE; St Hill CR; Hagendoorn L; Martin RC; Stromberg AJ; Scoggins CR
    Am Surg; 2011 Aug; 77(8):992-7. PubMed ID: 21944512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features.
    Nagarajan P; Piao J; Ning J; Noordenbos LE; Curry JL; Torres-Cabala CA; Diwan AH; Ivan D; Aung PP; Ross MI; Royal RE; Wargo JA; Wang WL; Samdani R; Lazar AJ; Rashid A; Davies MA; Prieto VG; Gershenwald JE; Tetzlaff MT
    Mod Pathol; 2020 Mar; 33(3):496-513. PubMed ID: 31383963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.
    Francken AB; Shaw HM; Thompson JF; Soong SJ; Accortt NA; Azzola MF; Scolyer RA; Milton GW; McCarthy WH; Colman MH; McGovern VJ
    Ann Surg Oncol; 2004 Apr; 11(4):426-33. PubMed ID: 15070604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can angiotropism and lymphovascular invasion refine the current cutaneous melanoma staging system?
    Namubiru P; Dalleywater W; Lashin S; Elsheikh S
    J Cutan Pathol; 2024 Apr; 51(4):288-298. PubMed ID: 38100196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant melanoma of the vulva: an extension of cutaneous melanoma?
    Moxley KM; Fader AN; Rose PG; Case AS; Mutch DG; Berry E; Schink JC; Kim CH; Chi DS; Moore KN
    Gynecol Oncol; 2011 Sep; 122(3):612-7. PubMed ID: 21570710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK; Buettner PG; Leiter U; Garbe C;
    J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
    Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
    Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases.
    Mandalà M; Galli F; Cattaneo L; Merelli B; Rulli E; Ribero S; Quaglino P; De Giorgi V; Pigozzo J; Sileni VC; Chirco A; Ferrucci PF; Occelli M; Imberti G; Piazzalunga D; Massi D; Tondini C; Queirolo P;
    J Am Acad Dermatol; 2017 Feb; 76(2):264-273.e2. PubMed ID: 27847125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.
    Tetzlaff MT; Curry JL; Ivan D; Wang WL; Torres-Cabala CA; Bassett RL; Valencia KM; McLemore MS; Ross MI; Prieto VG
    Mod Pathol; 2013 Sep; 26(9):1153-60. PubMed ID: 23558574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature.
    Loghavi S; Curry JL; Torres-Cabala CA; Ivan D; Patel KP; Mehrotra M; Bassett R; Prieto VG; Tetzlaff MT
    Mod Pathol; 2014 Nov; 27(11):1468-78. PubMed ID: 24743221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and validation of a prognostic nomogram for primary vulvar melanoma: a SEER population-based study.
    Zhou H; Zou X; Li H; Chen L; Cheng X
    Jpn J Clin Oncol; 2020 Dec; 50(12):1386-1394. PubMed ID: 32776099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.
    Azzola MF; Shaw HM; Thompson JF; Soong SJ; Scolyer RA; Watson GF; Colman MH; Zhang Y
    Cancer; 2003 Mar; 97(6):1488-98. PubMed ID: 12627514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant melanoma of the vulva. Report of 89 patients.
    Räber G; Mempel V; Jackisch C; Hundeiker M; Heinecke A; Kürzl R; Glaubitz M; Rompel R; Schneider HP
    Cancer; 1996 Dec; 78(11):2353-8. PubMed ID: 8941006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker.
    Heinzelmann-Schwarz VA; Nixdorf S; Valadan M; Diczbalis M; Olivier J; Otton G; Fedier A; Hacker NF; Scurry JP
    Int J Mol Med; 2014 Apr; 33(4):784-94. PubMed ID: 24535703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.